Yoğun Bakım
Antikoagülan Tedavi ve Antikoagülasyonun Tersine Çevrilmesi
Reversal of antithrombotic agents. (yeni pencere açar)
Kaynak: Am J Hematol 2012;87 Suppl 1:S119-26.
Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. (yeni pencere açar)
Kaynak: J Thromb Haemost 2015;13(10):1790-8.
Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. (yeni pencere açar)
Kaynak: N Engl J Med 2019;380(14):1326-35.
Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. (yeni pencere açar)
Kaynak: N Engl J Med 2016;375(12):1131-41.
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. (yeni pencere açar)
Kaynak: Circulation 2011;124(14):1573-9.
Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (yeni pencere açar)
Kaynak: Lancet 2015;385(9982):2077-87.
Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. (yeni pencere açar)
Kaynak: J Trauma Acute Care Surg 2013;75(3):475-86.
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (yeni pencere açar)
Kaynak: Am J Hematol 2012;87 Suppl 1:S141-5.
Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (yeni pencere açar)
Kaynak: J Thromb Haemost 2011;9(9):1705-12.
Emergency reversal of warfarin anticoagulation. (yeni pencere açar)
Kaynak: CMAJ 2010;182(18):2004.
Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (yeni pencere açar)
Kaynak: Thromb Haemost 2012;108(2):217-24.
Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. (yeni pencere açar)
Kaynak: J Thromb Haemost 2008;6(4):622-31.
Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. (yeni pencere açar)
Kaynak: Blood Adv 2019;3(2):158-67.
Idarucizumab for dabigatran reversal. (yeni pencere açar)
Kaynak: N Engl J Med 2015;373(6):511-20.
Idarucizumab for dabigatran reversal - full cohort analysis. (yeni pencere açar)
Kaynak: N Engl J Med 2017;377(5):431-41.
Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. (yeni pencere açar)
Kaynak: Blood 2003;102(13):4594-9.
Role of agents for reversing the effects of target-specific oral anticoagulants. (yeni pencere açar)
Kaynak: Am J Health Syst Pharm 2017;74(2):54-61.
Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (yeni pencere açar)
Kaynak: Anesth Analg 2011;113(4):703-10.
2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (yeni pencere açar)
Kaynak: J Am Coll Cardiol 2017;70(24):3042-67.
Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (yeni pencere açar)
Kaynak: World Neurosurg 2014;81(1):110-5.
Reversal of warfarin-induced hemorrhage in the emergency department. (yeni pencere açar)
Kaynak: West J Emerg Med 2011;12(4):386-92.